touchENDOCRINOLOGY were delighted to catch up with Dr. Andrea R. Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to discuss the health burden of osteoporosis in post-menopausal women and how HRT could be used as a prevention strategy.
‘Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for how long‘ was presented at WCO IOF-ESCEO 2022, 24-26 March, 2022
Questions
- Could you give us a brief overview of the health burden of osteoporosis in post-menopausal women? (1:15)
- What evidence exists for the efficacy of hormone replacement therapy (HRT) for bone loss prevention in post-menopausal women? (2:44)
Disclosures: Andrea R. Genazzani has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the WCO IOF-ESCEO annual meeting 2022.
